乱淫AV一区,9久九九精品视频,久久草在线播放

AbbVie's Bold Claim: To Become the Largest CNS Company Next Year! AbbVie AbbVie sets its sights on becoming the top CNS company by 2026, driven by strong H1 growth, strategic acquisitions, and breakthrough treatments in neuroscience, including schizophrenia, migraine, and Parkinson’s disease.
Pfizer Secures Global Rights to SSGJ-707: A Next-Gen PD-1/VEGF Bispecific for Cancer Treatment Pfizer Pfizer acquires global rights to SSGJ-707, a PD-1/VEGF bispecific antibody from 3SBio, aiming to enhance its oncology pipeline with a novel mechanism and strong clinical potential.
WuXi AppTec Q2 2025 Earnings Report Financial statements U.S. CDMOs face strategic setbacks amid global supply chain shifts, while China, South Korea, and Europe intensify competition in high-growth biotech sectors like CGT and ADC, reshaping the global CDMO landscape.
Basf Q2 2025 Earnings Report Financial statements BASF's Q2 2025 net income plunged 81.4% amid weak demand and falling prices. The company adjusted its full-year forecast and announced key updates on its PA6.6 and Styrodur? businesses, including acquisitions and divestitures.
Shanghai-Suzhou: Biopharma's Next hub? Market Trend As the global race in the biopharmaceutical industry accelerates, the Shanghai-Suzhou cluster is emerging as a powerful contender. Ranked 9th worldwide by the 2024 MedCity report, this dynamic duo from China is challenging the dominance of legacy giants like Boston, NewYork, and London.
China Surpasses US in Clinical Trials: Leading Global Biotechnology Innovation in 2024 Market Trend China has surpassed the US in clinical trial numbers in 2024, leading global biotech innovation. Major pharma licensing, rising patents, and booming R&D hubs highlight China’s growing dominance in healthcare research.
China Cosmetics Export Soars 14.1% in Q1, Domestic Brands Capture New International Market Track Import & Export In Q1 2025, China's cosmetics exports rose 14.1%, driven by strong growth in emerging markets and rising global demand for domestic brands. Despite import declines, China’s beauty industry shows strong international momentum.
ASCO 2025: AstraZeneca's Breakthrough Innovations in Cancer Treatment Leading Global Oncology Advances ASCO Discover AstraZeneca’s groundbreaking cancer research at ASCO 2025, featuring innovative therapies in breast, lung, and digestive cancers. Leading global oncology with advanced treatments and strategic local-global integration.
ASCO 2025: BMS Defends Opdualag's Future After Adjuvant Melanoma Setback BMS Bristol Myers Squibb’s Opdualag failed to improve outcomes in adjuvant melanoma, raising questions about LAG-3 antibodies. Despite this, BMS remains confident in ongoing NSCLC trials targeting PD-1 positive patients.
Kura and Kyowa's Ziftomenib Shows 23% Remission in AML Trial ASCO Kura Oncology and Kyowa Kirin announced a 23% remission rate in their phase 2 trial of oral leukemia drug ziftomenib for relapsed/refractory NPM1-mutant AML, with FDA approval under review and phase 3 trials planned.

< Pre 1...15 16 171819 20 21...26 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水